Alkermes plc (ALKS)Officer sold ~$202K

~$202K

Approx. value · 6,890 sh @ $29.29

7,717

Holds after · shares reported

Traded

Mar 2, 2026

Filed

Mar 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 2, 2026InsiderOfficer sold ~$112K of ALKS shares in the open market
2. Jan 8, 2026InsiderOfficer sold ~$150K of ALKS shares in the open market
3. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
4. Feb 2, 2026Insider · 2 peopleInsiders: 4 sales (~$2.4M)
5. Feb 12, 2026Company filing · Form 8-K · Material agreement, Agreement endedCompleted buying or selling a business or assets, and signed an important agreement (and 3 more items)“On February 12, 2026, the Company and Avadel Pharmaceuticals plc (“Avadel”), completed the transactions contemplated by the previously announced Transaction Agreement (the “Original Transaction Agreement”) dated October 22, 2025, as amended by Amendment No.1 to the Transaction Agreement (the “Amendment”) dated November 18, 2025, by and between the Company and Avadel (as amended, the “Transaction Agreement”).”
6. Feb 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 24, 2026, Richard F. Pops, Chairman and Chief Executive Officer of Alkermes plc (the “Company”), notified the Company’s board of directors (the “Board”) of his decision to retire from his position of Chief Executive Officer, effective July 31, 2026, following a distinguished 35 years of service in this role.”
7. Feb 25, 2026Company filing · Form 8-K · ResultsReported its results
8. Mar 2, 2026 · this disclosureInsiderOfficer sold ~$202K of ALKS shares in the open market

What came next

1. Mar 2, 2026Insider · 3 peopleInsiders: 3 sales (~$507K)
2. Mar 3, 2026InsiderOfficer sold ~$61K of ALKS shares in the open market
3. Apr 1, 2026InsiderOfficer sold ~$320K of ALKS shares in the open market
4. Apr 6, 2026InsiderOfficer sold ~$70K of ALKS shares in the open market
5. May 1, 2026InsiderOfficer sold ~$301K of ALKS shares in the open market
6. May 4, 2026InsiderOfficer sold ~$68K of ALKS shares in the open market
7. May 5, 2026Company filing · Form 8-K · ResultsReported its results
8. May 20, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 20, 2026, at the 2026 annual general meeting of shareholders (the “Annual Meeting”) of Alkermes plc (the “Company”), the Company’s shareholders approved amendments to the Alkermes plc 2018 Stock Option and Incentive Plan to, among other things, increase the number of the Company’s ordinary shares authorized for issuance thereunder by 5,900,000 (the plan as so amended, the “2018 Plan”).”
9. May 29, 2026InsiderOfficer sold ~$687K of ALKS shares in the open market
10. Jun 1, 2026InsiderOfficer sold ~$375K of ALKS shares in the open market
11. Jun 4, 2026InsiderOfficer sold ~$88K of ALKS shares in the open market
12. Jun 12, 2026InsiderDirector sold ~$90K of ALKS shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alkermes plc

For Alkermes plc, OQRO holds 9 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALKS page.

Other recent filings by Samuel Joseph Parisi, VP, Finance (Interim PAO)

• SEC Form 4 at Alkermes plc (ALKS)May 29, 2026
• SEC Form 4 at Alkermes plc (ALKS)Feb 28, 2025
• SEC Form 4 at Alkermes plc (ALKS)Feb 25, 2025
• SEC Form 4 at Alkermes plc (ALKS)Feb 20, 2025

The full history of Samuel Joseph Parisi, VP, Finance (Interim PAO) is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Alkermes plc

• SEC Form 4Oct 2, 2026
• SEC Form 144Oct 2, 2026
• House Clerk periodic transaction reportSep 4, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 4Sep 1, 2026
• SEC Form 4Aug 17, 2026

Everything OQRO holds on this company is on its ALKS page.